As part of the Kentucky Opioid Response Effort (KORE), the Department for Behavioral Health, Developmental and Intellectual Disabilities (DBHDID) will award up to 12 Medications for Opioid Use Disorder (MOUD) Treatment Access Expansion grants. Applications are due November 13, 2020. Please find attached the Notice of Funding Opportunity announcement, which includes applicant instructions and eligibility, the budget template and planning guide and an attestation to access to FDA-Approved Medications for Opioid Use Disorder (MOUD). The lead applicant must be a nonprofit organization with 501c3 status. For-profit agencies may partner as a sub-awardee or sub-recipient of the nonprofit organization.
Despite MOUD being the standard of care, many individuals in Kentucky have little to no access to evidence-based treatment. The purpose of the Treatment Access Expansion grants is to increase access to and utilization of the three FDA-approved medications, reduce unmet treatment need, provide assertive engagement with the most vulnerable populations, and reduce opioid-related overdose deaths. Treatment Access Expansion grants will support eligible agencies to implement or expand an evidence-based service delivery model using MOUD. Further, this unprecedented period during which the COVID-19 pandemic has collided with the opioid epidemic, individuals with Opioid Use Disorder (OUD) have been severely impacted not only through a greater risk of contracting the virus and becoming ill, but in experiencing more difficulty accessing treatment, recovery and harm reduction services as well as social groups of support. This is particularly true for individuals in our communities who may be houseless, lack transportation and internet access to participate in virtual treatment and mutual aid platforms and for Black, Indigenous and People of Color (BIPOC) who are experiencing increased risks due to systemic health and social inequities. Thus, priority will be given to applications presenting innovative solutions to serve populations most at risk and reduce health disparities in the context of COVID-19.
A link to the application materials is also available on our website here.
Notice of Funding Opportunity Information Sheet
Attestation to Support Access to FDA-Approved Medications for Opioid Use Disorder
Kentucky Opioid Response Effort
Amanda Foley-Byard, PhD
Treatment Implementation Specialist – Kentucky Opioid Response Effort
Department for Behavioral Health, Developmental and Intellectual Disabilities
Cabinet for Health and Family Services